A 68-year-old man is diagnosed with symptomatic benign prostatic hyperplasia (BPH). His International Prostate Symptom Score (IPSS) is 15 (moderate). He has no significant comorbidities. After discussion of options, he wishes to try medical therapy. According to NICE CG97, what is an appropriate first-line pharmacological agent to offer?